(MENAFN- GlobeNewsWire - Nasdaq) Company's prospective, multi-center 240-patient, pivotal randomized controlled trial (RCT) earns AUA“Practice-changing, Paradigm-shifting Clinical Trials in Urology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results